|
|
Post by magnus123 on Feb 16, 2021 17:49:01 GMT
Just doubled down at $4.58. Should have been patient at the beginning of the day, but of course FOMO kicked in, lol. Still have some room to add if it goes lower. Welcome aboard! I bought too high as well, having a decent position now, but i don't care a lot about pennies, if we get $10 or more  OPTN is doing well in a rough market. Very good entry point in my opinion. |
|
|
|
Post by magnus123 on Feb 17, 2021 14:51:46 GMT
Added again at $4.55.
|
|
|
|
Post by JHam on Feb 17, 2021 15:04:15 GMT
Nice. I have a small order in at $4.51 waiting to see if I get any bites. I’ll walk it up if I need to. |
|
|
|
Post by JHam on Feb 17, 2021 15:09:11 GMT
And it just filled. Have another order in now at $4.46.
|
|
|
|
Post by JHam on Feb 18, 2021 15:39:53 GMT
Been averaging down like crazy here today. It’s currently my largest (and only) position, lol. That will change soon though. No problem holding this one for the long haul as the market starts to realize the value play opportunity here, or until they are bought out.
|
|
|
|
Post by magnus123 on Feb 18, 2021 15:44:57 GMT
Been averaging down like crazy here today. It’s currently my largest (and only) position, lol. That will change soon though. No problem holding this one for the long haul as the market starts to realize the value play opportunity here, or until they are bought out. I'm also massively invested here. I have 30% in cash after my CLPS profit and OPTN is such a steal. I like to compare it with EDRY before it's Q3 earnings, where ecoethcon and myself exactly knew that the stock would go crazy. And while OPTN is much more uncertain, it has so much to offer at current prices. It may dip to $4, which is a strong support level since Q3 earnings and i will buy more then. |
|
|
|
Post by JHam on Feb 18, 2021 16:27:33 GMT
Been averaging down like crazy here today. It’s currently my largest (and only) position, lol. That will change soon though. No problem holding this one for the long haul as the market starts to realize the value play opportunity here, or until they are bought out. I'm also massively invested here. I have 30% in cash after my CLPS profit and OPTN is such a steal. I like to compare it with EDRY before it's Q3 earnings, where ecoethcon and myself exactly knew that the stock would go crazy. And while OPTN is much more uncertain, it has so much to offer at current prices. It may dip to $4, which is a strong support level since Q3 earnings and i will buy more then. OPTN feels like it should be as certain as EDRY just based on the fact that it is barely trading at 2x 2021 consensus revenues. Here is the slide, courtesy of Boston Biotech, that is most important heading into ER next month. The red circle is consensus estimates for 4Q20:  |
|
|
|
Post by magnus123 on Feb 18, 2021 16:46:11 GMT
I'm also massively invested here. I have 30% in cash after my CLPS profit and OPTN is such a steal. I like to compare it with EDRY before it's Q3 earnings, where ecoethcon and myself exactly knew that the stock would go crazy. And while OPTN is much more uncertain, it has so much to offer at current prices. It may dip to $4, which is a strong support level since Q3 earnings and i will buy more then. OPTN feels like it should be as certain as EDRY just based on the fact that it is barely trading at 2x 2021 consensus revenues. Here is the slide, courtesy of Boston Biotech, that is most important heading into ER next month. The red circle is consensus estimates for 4Q20: View AttachmentThanks for providing this. They should beat the $18m revenue very likely in my opinion. This should attract the interest of traders seeing the Reuters or BZ headline "OPTN beats revenue est., beats EPS est." If we get this scenario, we should finally break out of the $4-5 range and elevate much higher. |
|
|
|
Post by JHam on Feb 18, 2021 17:04:23 GMT
OPTN feels like it should be as certain as EDRY just based on the fact that it is barely trading at 2x 2021 consensus revenues. Here is the slide, courtesy of Boston Biotech, that is most important heading into ER next month. The red circle is consensus estimates for 4Q20: View AttachmentThanks for providing this. They should beat the $18m revenue very likely in my opinion. This should attract the interest of traders seeing the Reuters or BZ headline "OPTN beats revenue est., beats EPS est." If we get this scenario, we should finally break out of the $4-5 range and elevate much higher. Good point about the headline. It’s not like they’re a penny stock. They are legit, raking in revenue, have a popular product, and have good analyst coverage. A bullish headline like that could really wake up this sleeping monster. |
|
|
|
Post by JHam on Feb 18, 2021 17:20:45 GMT
Nice little recovery going on here today. Started the day averaged at $4.65. Now averaged at $4.48.
|
|
|
|
Post by magnus123 on Feb 21, 2021 10:12:16 GMT
OPTN is now my second largest holding behind QUIK.
"It’s not like they’re a penny stock. They are legit, raking in revenue, have a popular product, and have good analyst coverage. A bullish headline like that could really wake up this sleeping monster. "
Yes!
|
|
|
|
Post by JHam on Feb 22, 2021 17:11:24 GMT
OPTN is now my second largest holding behind QUIK. "It’s not like they’re a penny stock. They are legit, raking in revenue, have a popular product, and have good analyst coverage. A bullish headline like that could really wake up this sleeping monster. " Yes! Continued to nibble down here today. I may do one more buy for now, but have a pretty big position. |
|
|
|
Post by JHam on Feb 23, 2021 0:01:40 GMT
I have been adding in small increments AH at $4.08. Can’t believe it is that low, but it is hard to resist. I figured these small buys would make it rise a little since the volume AH is so small, but I may keep adding if it the ask doesn’t budge.
|
|
|
|
Post by JHam on Feb 23, 2021 0:26:41 GMT
Been averaging down like crazy here today. It’s currently my largest (and only) position, lol. That will change soon though. No problem holding this one for the long haul as the market starts to realize the value play opportunity here, or until they are bought out. I'm also massively invested here. I have 30% in cash after my CLPS profit and OPTN is such a steal. I like to compare it with EDRY before it's Q3 earnings, where ecoethcon and myself exactly knew that the stock would go crazy. And while OPTN is much more uncertain, it has so much to offer at current prices. It may dip to $4, which is a strong support level since Q3 earnings and i will buy more then. Inching closer to your $4 mark. |
|
|
|
Post by JHam on Feb 23, 2021 0:38:33 GMT
They still haven't announced anything on their OPN-019 COVID-19 candidate yet despite saying they expected results back in November:
www.sec.gov/ix?doc=/Archives/edgar/data/1494650/000149465020000136/optn-20200930.htm
OPN-019
In June 2020, we announced the initiation of development of a new product candidate, OPN-019. OPN-019 will combine the Company’s proprietary nasal Exhalation Delivery System (EDS) with an antiseptic.
We have performed in vitro testing against SARS-CoV-2 with a candidate formulation in which a 4-log reduction (a 99.99% reduction) in virus count was produced. In addition, we are performing tests against other pathogens and expect results in November.
Because components of the drug-device combination product candidate, including both the active drug and delivery device, are currently commercially available in the U.S., we anticipate streamlined and accelerated development. Subsequent to a pre-Investigational New Drug (IND) submission we have engaged with FDA regarding an IND and clinical development pathway.
We are focused on supporting the initial stages of development within our current operating expense guidance and intend to seek grants, partnerships, and/or other sources of capital to fund future development.
CEO Miller said on the last CC that the results were as good as expected. But they want to push the program further only with grants or so to not hike operating costs. I think that they really want to push through break even. www.purdueexponent.org/article_1a806175-84f1-5056-9460-7d2d6e944112.htmlI have to say honestly, that out of all things that make me bullish about this company, the COVID program (OPN-019) is not one of them. At this point I think it will be a hard sell to get people to put a funny looking device up their nose in order to kill the coronavirus as a preventative measure. Some people would probably even think it seems scammy, regardless of what the data says. It’s hard enough to get people just to wear masks, lol. I think a positive headline could cause a bump, but in general I’m not expecting much from OPN-019. I’m even wondering if they announce that they are discontinuing the program on the ER call. It would be a nice cherry on top if it works out, but for now it doesn’t really factor much into my thesis here. Hope I’m wrong of course. |
|
|
|
Post by lcd on Feb 23, 2021 2:57:41 GMT
I took a small position at the end of the trading day when it dipped below $4.20. Thanks for sharing your DD on this one!
|
|
|
|
Post by magnus123 on Feb 23, 2021 13:20:02 GMT
I have to say honestly, that out of all things that make me bullish about this company, the COVID program (OPN-019) is not one of them. At this point I think it will be a hard sell to get people to put a funny looking device up their nose in order to kill the coronavirus as a preventative measure. Some people would probably even think it seems scammy, regardless of what the data says. It’s hard enough to get people just to wear masks, lol. I think a positive headline could cause a bump, but in general I’m not expecting much from OPN-019. I’m even wondering if they announce that they are discontinuing the program on the ER call. It would be a nice cherry on top if it works out, but for now it doesn’t really factor much into my thesis here. Hope I’m wrong of course. I give zero value to their covid program. It's nice to have, but it's not worth the costs in my opinion. I want to see them become profitable and this program would certainly not help. If i understand correctly, the program is inactive. They will only develop it, when someone else pays them. |
|
|
|
Post by JHam on Feb 23, 2021 13:23:51 GMT
I took a small position at the end of the trading day when it dipped below $4.20. Thanks for sharing your DD on this one! Thanks again to Magnus for finding this one. I added a good amount yesterday AH. This is one that I feel pretty comfortable accumulating. I have enough shares but will set aside some cash in the event that it dips below $4. |
|
|
|
Post by JHam on Feb 23, 2021 13:24:12 GMT
I have to say honestly, that out of all things that make me bullish about this company, the COVID program (OPN-019) is not one of them. At this point I think it will be a hard sell to get people to put a funny looking device up their nose in order to kill the coronavirus as a preventative measure. Some people would probably even think it seems scammy, regardless of what the data says. It’s hard enough to get people just to wear masks, lol. I think a positive headline could cause a bump, but in general I’m not expecting much from OPN-019. I’m even wondering if they announce that they are discontinuing the program on the ER call. It would be a nice cherry on top if it works out, but for now it doesn’t really factor much into my thesis here. Hope I’m wrong of course. I give zero value to their covid program. It's nice to have, but it's not worth the costs in my opinion. I want to see them become profitable and this program would certainly not help. If i understand correctly, the program is inactive. They will only develop it, when someone else pays them. That sounds about right. |
|
|
|
Post by JHam on Feb 23, 2021 14:38:55 GMT
Despite everything else getting destroyed this is holding up reasonably well so far.
|
|
